A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke

Active, not recruiting

Phase 1/2 Results N/A

Summary of Purpose

The purpose of this study is to assess the safety and tolerability of allogeneic adult mesenchymal bone marrow cells administered intravenously to patients with ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 25 April 2017.

1 Feb 2011 10 Feb 2011 1 Sep 2017 1 Dec 2017 1 Apr 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts

  • Michael L Levy, MD, PhD FACS

    858-966-8574

  • Ann Campbell, RN, BSN, CCRC

    602-214-0886

  • Sarah E Holland, RN, MSN, CCRC

    858-966-8153

See All